Milestone(MIST)04-30 05:15
$Milestone(MIST)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-24-054157 Act: 34 Size: 612 KB 网页链接查看全文
Milestone(MIST)05-13 19:35
$Milestone(MIST)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-060221 Act: 34 Size: 309 KB 网页链接查看全文
Milestone(MIST)05-29 19:35
$Milestone(MIST)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-065806 Act: 34 Size: 267 KB 网页链接查看全文
Milestone(MIST)07-16 04:05
$Milestone(MIST)$ 8-K Current report, items 1.01, 5.02, 5.08, 8.01, and 9.01 Accession Number: 0001104659-24-079854 Act: 34 Size: 374 KB 网页链接查看全文
Milestone(MIST)07-16 04:45
$Milestone(MIST)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-079882 Act: 34 Size: 5 MB 网页链接查看全文
Milestone(MIST)07-16 04:45
$Milestone(MIST)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-079881 Act: 34 Size: 1 MB 网页链接查看全文
Milestone(MIST)07-18 04:25
$Milestone(MIST)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-019662 Size: 9 KB 网页链接查看全文
Milestone(MIST)07-18 04:25
$Milestone(MIST)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-019666 Size: 9 KB 网页链接查看全文
Milestone(MIST)07-18 04:25
$Milestone(MIST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019668 Size: 5 KB 网页链接查看全文
装逼备忘录2020-03-24 09:14
#新冠肺炎# 股票今日表现
$Hoth Therapeutics(HOTH)$ +35% (-6% AH offering)
$Adma生物制品(ADMA)$ +36%
$Milestone制药(MIST)$ late-stage fail -76% AH查看全文
淘沙见金2020-03-08 10:35
这周美股走势真心不一般,爆一天崩两天,每天看着指数上下翻飞,正可谓自春来,喜绿愁红,芳心是事可可。各位老司机你们出来说说,这种刺激上哪里找去?
最近药股的热点全跟疫情相关,什么CODX/INO等概念股轮番被热炒,短短几天股价翻了好多倍。没有赶上的同学也不用着急,毕竟市场上机会一大...查看全文
智通财经APP获悉,总部位于加拿大的Milestone Pharmaceuticals(MIST.US)当地时间周二宣布,美国食品和药物管理局(FDA)拒绝接受其主要候选药物etripamil的新药上市申请(NDA)。此负面消息一出,Milestone股价在美股盘前一度下跌约40%。 ... 网页链接
智通财经APP获悉,生物制药公司Milestone Pharmaceuticals(MIST.US)周一宣布,其主要药物etripamil在一项治疗阵发性室上性心动过速(PSVT)患者的3期临床试验中达到了主要终点。截至发稿,Milestone Pharmaceuticals盘前涨35.45%,报11.50... 网页链接
$Milestone(MIST)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-019662 Size: 9 KB 网页链接
$Milestone(MIST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019664 Size: 5 KB 网页链接
$Milestone(MIST)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-019666 Size: 9 KB 网页链接
$Milestone(MIST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019668 Size: 5 KB 网页链接
$Milestone(MIST)$ SC 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000921895-24-001575 Act: 34 Size: 105 KB 网页链接
$Milestone(MIST)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-079880 Act: 34 Size: 155 KB 网页链接
$Milestone(MIST)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-079881 Act: 34 Size: 1 MB 网页链接
$Milestone(MIST)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-079882 Act: 34 Size: 5 MB 网页链接
$Milestone(MIST)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-079878 Act: 34 Size: 1 MB 网页链接
$Milestone(MIST)$ 8-K Current report, items 1.01, 5.02, 5.08, 8.01, and 9.01 Accession Number: 0001104659-24-079854 Act: 34 Size: 374 KB 网页链接